Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9285
Peer-review started: June 3, 2021
First decision: June 25, 2021
Revised: June 30, 2021
Accepted: August 23, 2021
Article in press: August 23, 2021
Published online: October 26, 2021
Processing time: 140 Days and 1.5 Hours
Colon cancer is a common malignant disease of the gastrointestinal tract and usually occurs at the junction of the rectum and sigmoid colon. Lymphatic and hematogenous metastases occur frequently in colon cancer and the most common metastatic sites include the liver, lung, peritoneum, bone, and lymph nodes. As a manifestation of advanced tumor spread and metastasis, soft tissue metastasis, especially skeletal muscle metastasis with bone metaplasia caused by colon cancer, is rare, accounting for less than 1% of metastases.
A 43-year-old male patient developed skeletal muscle metastasis with bone metaplasia of the right proximal thigh 5 mo after colon cancer was diagnosed. The patient was admitted to the hospital because of pain caused by a local mass on his right thigh. Positron emission tomography-computed tomography showed many enlarged lymph nodes around the abdominal aorta but no signs of lung or liver metastases. Color ultrasound revealed a mass located in the skeletal muscle and the results of histological biopsy revealed a poorly differentiated adenocarcinoma suspected to be distant metastases from colon cancer. Immunohistochemistry showed small woven bone components that were considered to be ossified.
This case reminds us that for patients with advanced colorectal tumors, we should be alert to the possibility of unconventional metastasis.
Core Tip: In this article, we report a rare case of a 43-year-old male patient who developed skeletal muscle metastasis with bone metaplasia of the right proximal thigh 5 mo after colon cancer was diagnosed. This article discusses the possible mechanism of epithelial to mesenchymal transition from the perspective of BRAF mutation and tumor mutation burden. It prompts the need to guard against the occurrence of secondary malignant tumors with unusual metastasis pathways in patients with advanced colorectal cancer (CRC). It also reminds us to pay attention to unexplained masses and other discomforts in patients with advanced CRC.